Vinegar for Heartburn relief tested in a small crossover study
Official title: Examining the Efficacy of Vinegar for Reducing Heartburn Symptoms Related to Gastroesophageal Reflux Disease (GERD)
Run by Arizona State University · NCT07927296 · Data updated 2026-11-12
This study tests whether liquid vinegar or a vinegar tablet can relieve heartburn symptoms in people who have regular heartburn but no erosive disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 22 (estimated) |
| Sponsor | Arizona State University Academic / other |
| Locations | 1 site (Phoenix, Arizona) |
| Status | Recruiting |
| Started | November 16, 2026 |
| Main results expected | May 15, 2027 |
| Study ends | May 15, 2027 |
| Registry record updated | November 10, 2026 |
| Trial ID | NCT07927296 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with regular heartburn (at least twice weekly) who do not have erosive reflux disease and can fast for four hours prior to testing.
✕Probably not a fit
Individuals with erosive esophagitis or other significant GI disorders, or those unable to tolerate vinegar may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized crossover trial compares liquid vinegar to a vinegar tablet as a treatment for heartburn in adults who experience symptoms at least twice weekly and do not have erosive reflux disease. Participants identify trigger foods and consume two targeted foods during two visits after a 4-hour fast, once with liquid vinegar and once with a vinegar tablet, in randomized order. Symptoms are reported every 10-15 minutes for two hours after eating using a validated heartburn measure. The study focuses on symptom relief rather than mechanisms of reflux, and aims to enroll 22 participants at a single site in Phoenix, Arizona. Both safety and tolerability of vinegar forms will be monitored during the trial.
Why it matters
Potential benefit: If successful, participants may experience reduced heartburn symptoms with vinegar-based interventions.
How similar studies have gone: This is among the first randomized crossovers to test vinegar forms for heartburn relief; prior data on this specific approach are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * report heartburn symptoms two or more times a week for several weeks or months * Any over the counter PPI use (proton-pump inhibitors such as Prilosec, Nexium, Prevacid) will need to be restricted for one month. Exclusion Criteria: * Drug use (prescription, over-the-counter, or otherwise) known to affect the stomach and digestive processes, including GLP-1 RA or GLP/GIP medications * Medical conditions that impact normal functioning of the gastrointestinal tract (e.g., Crohn's disease, Celiac disease, short bowel syndrome, ostomy, lactose intolerance, hernia , SIBO, H. Pylori positive hasn't been cleared etc.). * Excess alcohol use (\>2 servings daily)
Where it's running
-
Arizona Biomedical Collaborative
Phoenix, Arizona, United States Recruiting
Study contacts
- Study coordinator: Carol Johnston, PhD
- Email: carol.johnston@asu.edu
- Phone: 6024963463
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gut health follow-along with Peachbiotic in adults
This single-arm study tests whether Peachbiotic taken daily for 12 weeks helps adults with gut symptoms feel better.
-
New topical treatment options for GERD symptoms
This trial tests a medical device to see if it relieves GERD symptoms and improves quality of life in adults compared with a placebo.
-
Examining the safety of vonoprazan in pregnant women and their babies
This study is testing whether taking vonoprazan during pregnancy is safe for both mothers and their babies by comparing outcomes between those who took the medication and those who didn’t.
-
Breath testing for small intestinal bacterial overgrowth after proton pump inhibitors
This study is testing if people with gastroesophageal reflux symptoms who have taken proton pump inhibitors have a higher chance of having small intestinal bacterial overgrowth by using breath tests.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.